Key facts
- It has raised $5.8M across 2 recorded rounds; the latest was Later Stage VC ($3.8M) in Apr 2026.
- Contamination Source Identification has filed 7 Form Ds with the SEC since 2020, most recently Apr 2025 ($1.7M sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Contamination Source Identification
Funding rounds
2 roundsAbout Contamination Source Identification
Operator of a diagnostics lab intended for active pathogen detection utilizing genomic technology. The company's test directly isolates and identifies any active bacterial, viral, or pathogenic microorganisms present in a sample, it detects a pathogen's RNA to identify active infections and is in the process of becoming clinically validated to identify both prosthetic joint infections as well as the causative agents of sepsis, enabling healthcare professionals to get clear and actionable pathogen identification for proper disease diagnosis and targeted treatment decisions.
- Sector
- Healthcare
- HQ
- Huntingdon, PA, United States
- Founded
- 2018
- Employees
- 12
- Website
- csidx.com/
- Ownership
- Privately Held (backing)
Contamination Source Identification doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Contamination Source Identification shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Contamination Source Identification in its N-PORT filings yet. We sweep new filings monthly.